Intellis™ Platform Rechargeable Spinal Cord Stimulation


Contact us
Front view of the Intellis neurostimulator


High-performance neurostimulator

The lntellis™ with AdaptiveStim™ rechargeable neurostimulator is powered by proprietary Overdrive™ battery technology. It is designed to overcome limitations with other SCS systems and is optimized for the increased energy demands of High Dose (HD) therapy.

  • Smallest fully implantable spinal cord neurostimulator
  • <1 hour recharge — empty to full (approximate time)1
  • Improved battery performance with minimal capacity fade (<5%)1
  • Designed for patient comfort and more flexible placement during the implant
  • AdaptiveStim™ technology automatically adjusts the therapy as your patient moves, delivering a personalized treatment based on seven unique body positions.
  • Snapshot™ reporting, powered by AdaptiveStim™ technology, allows physicians to objectively monitor a patient's progress.
The Intellis product family for spinal cord stimulation

Not all batteries are created equal

9-year Overdrive™ battery data1

Medtronic is the only SCS manufacturer to offer this proprietary, nontraditional lithium ion battery chemistry.

Overdrive™ Battery Technology

  • Faster recharge*
  • Minimal fade*
  • Overdischarge protection

What could your patients do with more time?

~1 hour recharge

from empty to full


up to
3x faster

than traditional lithium ion batteries*


Patient can recharge

a completely discharged device


more than

battery capacity
at 9 years1, independent of therapy parameters or recharge preferences


Choose innovative battery technology

Improvements made to benefit your patients' needs and comfort

Implant depth
of up to
3 cm

provides versatility and patient comfort


due to flipped batteries or over-discharged batteries


Meets the demands of current and future workflows

including optimization for increased energy demands of HD therapies

Unrivaled battery chemistry performance

Our Overdrive™ battery technology has a proprietary chemistry compared with SCS competitor batteries that are based on conventional Li ion chemistry. Our design allows for rapid recharge with minimal impact to the battery capacity at 9 years of use even with full discharge.

Under daily, empty-to-full charge and discharge testing:

  • Medtronic’s Intellis™ Overdrive™ battery technology maintained 95% of the original capacity at 9 years and 3,200 cycles.1,2
  • The tested Competitor X spinal cord stimulators lost 30% of the capacity after only 3 years and 1,000 cycles.1,2
  • The Intellis™ devices can be recharged in ~1 hour from empty to full vs. up to 4 hours with the tested Competitor X devices.

Thus, patients will have a more consistent recharge interval and faster recharge experience, even under the most aggressive stimulation conditions.

Overdrive Intellis
Manufacturer X

Compatible products and features

Wireless External Neurostimulator

  • Wireless, sterile single-use external neurostimulator simplifies testing during trial and implant
  • Designed for patient comfort and convenience
Model Number 97725
Weight 71g (2.5oz)
Length 79mm (3.1in)
Width 74mm (2.9in)
Battery Type Non-rechargeable
Thickness 20mm (0.8in)
Front view of the Intellis wireless external neurostimulator

Clinician Programmer

  • Secure, wireless programming outside the sterile field
  • Tailored programming workflows
  • Electronic transfer of a variety of reports
  • Bluetooth® communication§
  • Requires the use of the Intellis™ clinician programmer app and communicator device
Clinician Programmer

Combined Patient Programmer and Recharger

  • Recharge from fully depleted battery
  • Easy-to-adjust therapy
  • Easy-to-read interface
  • Large, pliable recharge antenna designed for patient comfort
Combined Patient Programmer and Recharger


  • 1x8 Vectris™ and Vectris™ SureScan™ MRI percutaneous leads and INJEX™ anchoring system models 97791 and 97792
  • 16-electrode Specify™ SureScan™ MRI surgical leads

Intellis™ with
AdaptiveStim™ technology

Model 97715
Channels 2
Volume 13.9cc
Height 57.1mm (2.2in)
Width 47.2mm (1.9in)

DTM™ SCS therapy

DTM™ SCS therapy is a proprietary therapy inspired by science and rooted in pre-clinical research, and adapted to provide superior clinical outcomes.

The DTM™ SCS 12-month RCT proved sustained superiority compared to conventional stimulation.3

  • DTM™ SCS has an 84% back pain responder rate at 12-months.
  • DTM™ SCS has a 69% profound back pain response rate (≥80% pain relief) at 12 months.

Unmatched full-body MRI access

  • SureScan™ MRI technology allows MRI scans anywhere on the body enabling diagnostic care.
  • Provide patients the same access as non-implanted patients — now and in the future.
  • Shielded leads and proprietary device safeguards help patients safely get an MRI.
  • Access matters — 98% of patients are expected to need at least 1 MRI within 10 years of implant.4

Manuals and technical guides

Access prescriber, implant, MRI, and other manuals on the Medtronic Manual Library. Search by the product name (Intellis™) or model number (97715). 



Compared to traditional lithium ion batteries

Descriptive comparison, including studies with similar design (RCT; randomization >100 subjects; comparing 2 SCS therapies; with at least 12-months follow up) and patient populations (inclusion/exclusion criteria; baseline demographics) with back pain responder rates reported. This is not based on a statistical analysis of outcomes between studies.

MR Safety Triangle Under specific conditions. Refer to product labeling for full list of conditions. Patients with non-Medtronic leads and an EMBSNV20 adaptor extension are not eligible for an MRI.


The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.™


R131649 RS2 Lithium-Ion Overdrive™ Rechargeable Battery DVT Report


Chao Hu, et. al. Remaining useful life assessment of lithium-ion batteries in implantable medical devices. Journal of Power Sources. January 31, 2018, Volume 375, pgs118-130.


Fishman M, Cordner H, Justiz R, et al. 12-Month Results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021; 00: 1–12. doi: 10.1111/papr.13066.


Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531–537.

See the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. [If using an MRI SureScan™ device, see the MRI SureScan™ technical manual before performing an MRI].

For further information, contact your local Medtronic representative.